Neurega 50 mg (Capsule)
Unit Price: ৳ 14.00 (5 x 10: ৳ 700.00)
Strip Price: ৳ 140.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Ibn sina pharmaceuticals ltd |
| Also available as |
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
Pharmacology
- Structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA)
- Binds with high affinity to the alpha2-delta site in central nervous system tissues
- Anti-nociceptive and antiseizure effects
Dosage
- Maximum recommended dose of 100 mg three times a day for adults with DPN
- Recommended dose of 75-150 mg two times a day for PHN in adults
- Recommended dose of 300-450 mg/day for fibromyalgia in adults
- Recommended dose range of 150-600 mg/day for neuropathic pain associated with spinal cord injury in adults
- Conversion guidelines from Pregabalin capsules to Pregabalin CR capsule tablet
Administration
- Oral route of administration
- Can be taken with or without food
- Pregabalin CR tablet should be administered after an evening meal
- Instructions on how to take Pregabalin CR tablet
Interaction
- Unlikely to be involved in significant pharmacokinetic drug interactions
- No significant interactions with food or others
Contraindications
- Contraindicated in patients with known hypersensitivity to Pregabalin
Side Effects
- Common side effects include dizziness, somnolence, dry mouth, edema, blurred vision, and weight gain
- Increased weight and appetite in pediatric patients
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Small amounts detected in the milk of lactating women
- Breastfeeding not recommended due to potential risk of tumorigenicity
Precautions & Warnings
- Risk of angioedema, hypersensitivity reactions, and suicidal thoughts
- Monitoring required for respiratory depression and dosage adjustments
- Potential for dizziness, somnolence, and impairment of driving ability
- Caution needed when coadministering with thiazolidinedione antidiabetic agents
Use in Special Populations
- Safety and effectiveness not established in pediatric patients
- Different considerations for various age groups
Overdose Effects
- Symptoms of overdose include reduced consciousness, agitation, seizures, and heart block
- General supportive care and monitoring recommended
Therapeutic Class
- Adjunct anti-epileptic drugs
- Primary anti-epileptic drugs
Storage Conditions
- Store below 30°C in a cool, dry place protected from light and moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C8H17NO2
- Chemical Structure Image provided
Common Questions about Neurega 50 mg Capsule
- Explanation of what Neurega 50 mg Capsule is used for
- Duration of use for improvement in health conditions
- Recommended frequency of use
- Guidelines for taking Neurega 50 mg Capsule with respect to meals
- Storage and disposal instructions
- Different effects of Neurega 50 mg Capsule for various diseases
- Consultation regarding the duration of intake
- Importance of continuing use even if feeling fine
- Information on simultaneous use with other medications
- Possibility of weight gain and advice on maintaining stable weight
Pediatric Uses
- Safety and effectiveness not established in pediatric patients
- Requirements for treatment in pediatric populations